ST Pharm Co.,Ltd., provides custom manufacturing services for active pharmaceutical ingredient and intermediates in South Korea and internationally. The company offers small molecule and generics, an ingredient for treating viral infections; oligonucleotide based products, such as siRNA/microRNA, antisense, aptamer, decoys, and other novel oligos; monomer; and mRNA for vaccines and therapeutics. It also offers pre-clinical and bioanalytical R and D solutions. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is headquartered in Siheung-si, South Korea.
Metrics to compare | 237690 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship237690PeersSector | |
---|---|---|---|---|
P/E Ratio | 57.5x | 11.4x | −0.5x | |
PEG Ratio | 2.21 | 0.01 | 0.00 | |
Price / Book | 3.4x | 1.0x | 2.6x | |
Price / LTM Sales | 6.2x | 0.7x | 3.2x | |
Upside (Analyst Target) | 28.0% | 26.9% | 45.3% | |
Fair Value Upside | Unlock | 31.3% | 7.4% | Unlock |